Brain-Immune Connection Described in New Research

Two studies from Harvard Medical School and MIT, published in Cell, investigate the connection between immune system activity and brain function, revealing how cytokines—immune signaling molecules—affect mood, anxiety, and social behavior. Conducted in mice, the research identifies specific brain-immune interactions that could inform future treatments for conditions such as anxiety disorders and autism.

In the first study, researchers examined how cytokines regulate anxiety by acting on neurons in the amygdala, the brain’s “fear center.” They found that cytokines IL-17A and IL-17C increased amygdalar activity, leading to heightened anxiety-like behaviors in mice, such as avoiding open spaces. Blocking IL-17A receptors unexpectedly raised levels of both IL-17A and IL-17C, worsening anxiety behaviors. Conversely, the anti-inflammatory cytokine IL-10 reduced amygdalar activity and alleviated anxiety. These results demonstrate how inflammatory and anti-inflammatory signals directly influence brain cells to shape emotional responses.

The second study explored cytokines’ role in improving social behavior in mice with autism-like traits. Cytokines such as IL-17E promoted social interaction and reduced repetitive behaviors. The team discovered that IL-17E is produced by neurons within the brain itself, suggesting it may act as a neuromodulator similar to serotonin or dopamine. This finding challenges prior assumptions about cytokine origins and opens new avenues for research into their role in brain function.

While these findings provide insight into brain-immune crosstalk, questions remain about their applicability to humans and how cytokines interact with the blood-brain barrier. If validated in human studies, this research could lead to therapies targeting immune signals to address mood and behavioral conditions without directly altering brain chemistry.